Abstract
The update on urticaria involves new concepts on the pathogenesis and the treatment of severe hives that are unresponsive to conventional treatments. A newly described autoantibody IgG against IgE receptor has been identified in some severe chronic urticaria patients. Anti-inflammatory and immunomodulating agents are being used with increasing frequency by academic faculty and other physicians in severe chronic idiopathic urticaria (CIU).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Allergy proceedings : the official journal of regional and state allergy societies
Paper Title
Journal
Date
